Stopping antiretroviral therapy
- 20 August 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 21 (13), 1673-1682
- https://doi.org/10.1097/qad.0b013e3281c61394
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trialThe Lancet, 2006
- Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmissionAIDS, 2006
- Treatment for Adult HIV InfectionJAMA, 2004
- A Proof‐of‐Concept Study of Short‐Cycle Intermittent Antiretroviral Therapy with a Once‐Daily Regimen of Didanosine, Lamivudine, and Efavirenz for the Treatment of Chronic HIV InfectionThe Journal of Infectious Diseases, 2004
- Clinical implications of stopping nevirapine-based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistanceHIV Medicine, 2004
- An open-label assessment of TMC 125–a new, next-generation NNRTI, for 7 days in HIV-1 infected individuals with NNRTI resistanceAIDS, 2003
- Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individualsAIDS, 2003
- Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patientsJournal of Antimicrobial Chemotherapy, 2003
- AbacavirDrugs, 1998
- Clinical Pharmacokinetics Of Nucleoside Antiretroviral AgentsThe Journal of Infectious Diseases, 1995